연속 혈당 모니터링(CGM) 기기 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 제품별, 접속성별, 적응증별, 유통 채널별, 지역별, 부문 예측(2025-2033년)
Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Standalone, Integrated), By Connectivity, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
상품코드
:
1813975
리서치사
:
Grand View Research
발행일
:
2025년 08월
페이지 정보
:
영문 195 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
연속 혈당 모니터링 기기 시장 개요
연속 혈당 모니터링 기기 시장 규모는 2024년에 136억 6,000만 달러로 평가되었고, 2033년에는 498억 7,000만 달러에 이를 것으로 예측되며, 2025-2033년 CAGR 15.44%로 성장할 것으로 전망됩니다.
이 성장은 임상 요구, 기술 혁신 및 관리 모델의 전환으로 인한 것입니다.
시장 성장의 또 다른 주요 요인은 당뇨병의 세계적인 유병률 증가이며, 보다 효율적이고 실시간 혈당 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 전통적인 혈당 검사는 침습적이고 간헐적이고 불편한 경우가 많으며 환자와 의료 제공업체 모두가 더 나은 혈당 조절과 삶의 질을 향상시키기 위해 CGM 시스템을 채택하도록 촉구하고 있습니다. 국제 당뇨병 연합(IDF)에 따르면 2024년 현재 세계 당뇨병 환자 수는 약 5억 8,900만 명입니다.
목차
제1장 조사 방법 및 범위
제2장 주요 요약
제3장 연속 혈당 모니터링(CGM) 기기 시장의 변수, 동향 및 범위
시장 계통 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
연속 혈당 모니터링(CGM) 기기 시장 분석 도구
업계 분석-Porter's Five Forces 분석
PESTEL 분석
제4장 연속 혈당 모니터링(CGM) 기기 시장의 추정 및 동향 분석 : 제품별
부문 대시보드
연속 혈당 모니터링(CGM) 기기 시장 변동 분석 : 제품별
연속 혈당 모니터링(CGM) 기기 시장 전망 : 제품별
시장 규모와 예측 및 동향 분석(2021-2033년)
독립형 CGM 디바이스
통합형 CGM 인슐린 펌프 시스템
제5장 연속 혈당 모니터링(CGM) 기기 시장의 추정 및 동향 분석 : 접속성별
부문 대시보드
연속 혈당 모니터링(CGM) 기기 시장 변동 분석 : 접속성별
연속 혈당 모니터링(CGM) 기기 시장 전망 : 접속성별
시장 규모와 예측 및 동향 분석(2021-2033년)
Bluetooth
4G 및 셀룰러
근거리 무선 통신(NFC)
제6장 연속 혈당 모니터링(CGM) 기기 시장의 추정 및 동향 분석 : 적응증별
부문 대시보드
연속 혈당 모니터링(CGM) 기기 시장 변동 분석 : 적응증별
연속 혈당 모니터링(CGM) 기기 시장 전망 : 적응증별
시장 규모와 예측 및 동향 분석(2021-2033년)
1형 당뇨병
2형 당뇨병
제7장 연속 혈당 모니터링(CGM) 기기 시장의 추정 및 동향 분석 : 유통 채널별
부문 대시보드
연속 혈당 모니터링(CGM) 기기 시장 변동 분석 : 유통 채널별
연속 혈당 모니터링(CGM) 기기 시장 전망 : 유통 채널별
시장 규모와 예측 및 동향 분석(2021-2033년)
약국
전자상거래
기타
제8장 연속 혈당 모니터링(CGM) 기기 시장의 추정 및 동향 분석 : 지역별
지역 대시보드
연속 혈당 모니터링(CGM) 기기 시장 변동 분석 : 지역별
연속 혈당 모니터링(CGM) 기기 시장 추정 및 동향 분석 : 지역별
시장 규모와 예측 및 동향 분석(2021-2033년)
북미
미국
캐나다
멕시코
유럽
영국
독일
프랑스
이탈리아
스페인
덴마크
스웨덴
노르웨이
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카
사우디아라비아
아랍에미리트(UAE)
쿠웨이트
제9장 경쟁 구도
시장 진출 기업의 분류
주요 기업 프로파일
DexCom, Inc.
Abbott Laboratories
Medtronic plc
Sensonics Holdings, Inc.
Insulet Corporation
Tandem Diabetes Care
Ascenia Diabetes Care(subsidiary of PHC Holdings)
AgaMatrix, Inc.
GlucoRx Limited
Zhejiang POCTech., Ltd.
iSENS, Inc.
F. Hoffmann-La Roche Ltd.
AJY
영문 목차
Continuous Glucose Monitoring Devices Market Summary
The continuous glucose monitoring devices market size was estimated at USD 13.66 billion in 2024 and is projected to reach USD 49.87 billion by 2033, growing at a CAGR of 15.44% from 2025 to 2033. This growth is attributed to clinical needs, technological innovation, and shifting care models.
Another primary factor for market growth is the rising global prevalence of diabetes, which has intensified the demand for more efficient and real-time glucose monitoring solutions. Traditional blood glucose testing is often invasive, intermittent, and inconvenient, prompting both patients and providers to adopt CGM systems for better glycemic control and improved quality of life. According to the International Diabetes Federation (IDF), as of 2024, there are approximately 589 million adults living with diabetes worldwide.
Global Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global continuous glucose monitoring (CGM) devices market report based on the product, connectivity, indication, distribution channel, and region:
Product Outlook (Revenue, USD Million, 2021 - 2033)
Standalone CGM Devices
Integrated-CGM Insulin Pump Systems
Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
Bluetooth
4G/Cellular
Near Field Communication (NFC)
Indication Outlook (Revenue, USD Million, 2021 - 2033)
Type 1 Diabetes
Type 2 Diabetes
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Pharmacies
E-commerce
Other
Region Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Connectivity
1.2.3. Indication
1.2.4. Distribution Channel
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Connectivity outlook
2.2.3. Indication outlook
2.2.4. Distribution channel outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Continuous Glucose Monitoring (CGM) Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising number of diabetes cases
3.2.1.2. Shift towards preventive and personalized care
3.2.1.3. Technological advancements and device innovation
3.2.1.4. Expansion of reimbursement and insurance coverage
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of CGM devices
3.2.2.2. Data accuracy and technical limitations
3.3. Continuous Glucose Monitoring (CGM) Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Continuous Glucose Monitoring (CGM) Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Continuous Glucose Monitoring (CGM) Devices Market: Product Movement Analysis
4.3. Continuous Glucose Monitoring (CGM) Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Standalone CGM Devices
4.5.1. Standalone CGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Devices
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Consumables
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Integrated-CGM Insulin Pump Systems
4.6.1. Integrated-CGM Insulin Pump Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Continuous Glucose Monitoring (CGM) Devices Market: Connectivity Movement Analysis
5.3. Continuous Glucose Monitoring (CGM) Devices Market by Connectivity Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Bluetooth
5.5.1. Bluetooth Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. 4G/Cellular
5.6.1. 4G/Cellular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Near Field Communication (NFC)
5.7.1. Near Field Communication Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Continuous Glucose Monitoring (CGM) Devices Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Continuous Glucose Monitoring (CGM) Devices Market: Indication Movement Analysis
6.3. Continuous Glucose Monitoring (CGM) Devices Market by Indication Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Type 1 Diabetes
6.5.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Type 2 Diabetes
6.6.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Continuous Glucose Monitoring (CGM) Devices Market: Distribution Channel Movement Analysis
7.3. Continuous Glucose Monitoring (CGM) Devices Market by Distribution Channel Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. Pharmacies
7.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. E-commerce
7.6.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Other
7.7.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Regional Continuous Glucose Monitoring (CGM) Devices Market Movement Analysis
8.3. Continuous Glucose Monitoring (CGM) Devices Market: Regional Estimates & Trend Analysis by Product & End-use
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.5. North America
8.5.1. North America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. U.S.
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement scenario
8.5.2.5. U.S. Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. Canada
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Canada Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Mexico Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. Europe
8.5.6. Europe Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. UK
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement scenario
8.5.7.5. UK Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.8. Germany
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement scenario
8.5.8.5. Germany Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.9. France
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement scenario
8.5.9.5. France Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.10. Italy
8.5.10.1. Key Country Dynamics
8.5.10.2. Competitive Scenario
8.5.10.3. Regulatory Framework
8.5.10.4. Reimbursement scenario
8.5.10.5. Italy Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.11. Spain
8.5.11.1. Key Country Dynamics
8.5.11.2. Competitive Scenario
8.5.11.3. Regulatory Framework
8.5.11.4. Reimbursement scenario
8.5.11.5. Spain Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.12. Denmark
8.5.12.1. Key Country Dynamics
8.5.12.2. Competitive Scenario
8.5.12.3. Regulatory Framework
8.5.12.4. Reimbursement scenario
8.5.12.5. Denmark Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.13. Sweden
8.5.13.1. Key Country Dynamics
8.5.13.2. Competitive Scenario
8.5.13.3. Regulatory Framework
8.5.13.4. Reimbursement scenario
8.5.13.5. Sweden Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.14. Norway
8.5.14.1. Key Country Dynamics
8.5.14.2. Competitive Scenario
8.5.14.3. Regulatory Framework
8.5.14.4. Reimbursement scenario
8.5.14.5. Norway Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Japan Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement scenario
8.6.3.5. China Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement scenario
8.6.4.5. India Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement scenario
8.6.5.5. South Korea Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement scenario
8.6.6.5. Australia Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement scenario
8.6.7.5. Thailand Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Brazil Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement scenario
8.7.3.5. Argentina Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement scenario
8.8.2.5. South Africa Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement scenario
8.8.3.5. Saudi Arabia Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement scenario
8.8.4.5. UAE Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement scenario
8.8.5.5. Kuwait Continuous Glucose Monitoring (CGM) Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. DexCom, Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott Laboratories
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Medtronic plc
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Sensonics Holdings, Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Insulet Corporation
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Tandem Diabetes Care
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Ascenia Diabetes Care (subsidiary of PHC Holdings)
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. AgaMatrix, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. GlucoRx Limited
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Zhejiang POCTech., Ltd.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. iSENS, Inc.
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. F. Hoffmann-La Roche Ltd.
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives
관련자료
